V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010433 | 250010835 | 1.6 | 69.6 | Curative (C) | 2017-02-06 | 2017-02-06 | Cisplatin + Pemetrexed | 02 | N | 250029902 | CISPLATIN + PEMETREXED |
| 250010434 | 250007632 | 1.76 | 0 | Palliative (P) | 2015-06-20 | 2015-06-28 | RUXOLITINIB | 02 | N | 250029903 | RUXOLITINIB |
| 250010435 | 250007633 | null | 53.2 | Palliative (P) | 2017-09-07 | 2017-09-07 | Vinorelbine (oral) | 02 | N | 250029913 | VINORELBINE |
| 250010436 | 250007634 | 1.8 | 59.3 | Curative (C) | 2016-02-18 | 2016-02-25 | RUXOLITINIB | N | N | 250029914 | RUXOLITINIB |
| 250010437 | 250007636 | 1.59 | 67.2 | Palliative (P) | 2013-10-31 | 2013-11-01 | Vinorelbine (oral) | 02 | N | 250029920 | VINORELBINE |
| 250010438 | 250007637 | 1.79 | 82 | Palliative (P) | 2012-06-22 | 2012-09-21 | RUXOLITINIB | N | N | 250029924 | RUXOLITINIB |
| 250010439 | 250007642 | 1.73 | null | Palliative (P) | 2013-07-25 | 2013-07-25 | VINORELBINE | N | N | 250029936 | VINORELBINE |
| 250010440 | 250010839 | 1.92 | 79 | Palliative (P) | 2016-07-24 | 2016-07-24 | Cisplatin + Pemetrexed | N | N | 250029937 | CISPLATIN + PEMETREXED |
| 250010442 | 250010840 | 1.59 | 69.2 | Disease modification (D) | 2018-03-24 | 2018-03-24 | Cisplatin + Pemetrexed | N | N | 250029945 | CISPLATIN + PEMETREXED |
| 250010443 | 250007644 | null | 79 | Curative (C) | 2017-07-14 | 2017-07-14 | Cisplatin + Pemetrexed | N | null | 250029945 | CISPLATIN + PEMETREXED |
| 250010444 | 250007646 | null | null | Palliative (P) | 2017-01-16 | 2017-01-23 | VINORELBINE | null | N | 250029954 | VINORELBINE |
| 250010445 | 250010842 | 1.67 | 101.4 | Disease modification (D) | 2015-07-13 | 2015-07-29 | Cisplatin + Pemetrexed | 02 | N | 250029956 | CISPLATIN + PEMETREXED |
| 250010446 | 250010842 | 1.68 | 77.3 | Neo-adjuvant (N) | 2014-03-26 | 2014-04-17 | Cisplatin + Pemetrexed | 02 | N | 250029956 | CISPLATIN + PEMETREXED |
| 250010447 | 250007647 | 1.74 | 71.8 | Palliative (P) | 2015-05-16 | 2015-05-16 | Vinorelbine (oral) | N | N | 250029966 | VINORELBINE |
| 250010448 | 250007648 | 1.62 | 68.7 | Disease modification (D) | 2014-01-15 | 2014-01-26 | Cisplatin + Pemetrexed | N | N | 250029980 | CISPLATIN + PEMETREXED |
| 250010449 | 250007652 | 1.7 | 71.9 | Palliative (P) | 2016-10-12 | 2017-01-25 | Vinorelbine (oral) | N | N | 250029983 | VINORELBINE |
| 250010450 | 250007653 | 0 | 69.5 | Disease modification (D) | 2018-09-13 | 2018-09-13 | Cisplatin + Pemetrexed | N | N | 250029984 | CISPLATIN + PEMETREXED |
| 250010451 | 250007654 | 1.71 | null | Disease modification (D) | 2015-02-22 | 2015-03-08 | Cisplatin + Pemetrexed | N | N | 250029991 | CISPLATIN + PEMETREXED |
| 250010452 | 250007655 | 0 | 79 | Palliative (P) | 2017-06-27 | 2017-07-12 | Vinorelbine (oral) | N | N | 250030001 | VINORELBINE |
| 250010453 | 250007655 | 1.62 | 100.2 | Palliative (P) | 2016-07-27 | 2016-08-05 | Vinorelbine (weekly iv) | N | N | 250030001 | VINORELBINE |
| 250010454 | 250007655 | 1.77 | 0 | Palliative (P) | 2014-02-06 | 2014-02-07 | Cisplatin + Pemetrexed | N | N | 250030001 | CISPLATIN + PEMETREXED |
| 250010458 | 250007659 | null | null | Palliative (P) | null | 2014-02-02 | Cisplatin + Pemetrexed | null | null | 250030038 | CISPLATIN + PEMETREXED |
| 250010459 | 250012093 | 1.9 | 79 | Palliative (P) | 2016-11-02 | 2017-11-28 | Vinorelbine (oral) | N | N | 250030038 | VINORELBINE |
| 250010461 | 250007661 | 1.58 | 48 | Disease modification (D) | 2015-07-30 | 2015-08-20 | Cisplatin + Pemetrexed | N | N | 250030040 | CISPLATIN + PEMETREXED |
| 250010462 | 250007664 | 1.71 | 0 | Disease modification (D) | 2013-03-09 | 2014-12-28 | RUXOLITINIB | N | N | 250030050 | RUXOLITINIB |
| 250010463 | 250007667 | 1.75 | null | Palliative (P) | 2017-09-24 | 2017-09-24 | Vinorelbine (oral) | N | N | 250030068 | VINORELBINE |
| 250010464 | 250007669 | 1.54 | 74.6 | Palliative (P) | 2014-03-07 | 2014-11-03 | RUXOLITINIB | N | N | 250030070 | RUXOLITINIB |
| 250010465 | 250007670 | 1.81 | 56 | Palliative (P) | 2017-05-27 | 2018-07-12 | Vinorelbine (oral) | N | Y | 250030078 | VINORELBINE |
| 250010467 | 250007672 | 0 | 69.4 | Disease modification (D) | 2017-08-08 | 2017-08-23 | RUXOLITINIB | N | N | 250030082 | RUXOLITINIB |
| 250010468 | 250007672 | 1.58 | 71.8 | Palliative (P) | 2013-12-27 | 2014-03-16 | RUXOLITINIB | N | N | 250030082 | RUXOLITINIB |
| 250010469 | 250012095 | 1.76 | 0 | null | 2014-11-25 | 2014-11-25 | Vinorelbine (oral) | N | N | 250030100 | VINORELBINE |
| 250010470 | 250012095 | 1.77 | 70 | Palliative (P) | 2014-05-02 | 2014-05-02 | Vinorelbine (oral) | N | N | 250030100 | VINORELBINE |
| 250010472 | 250010854 | 1.65 | 0 | Palliative (P) | 2013-12-17 | 2013-12-17 | Vinorelbine (oral) | N | N | 250030120 | VINORELBINE |
| 250010474 | 250007677 | 1.69 | 74.6 | Adjuvant (A) | 2017-03-29 | 2017-04-27 | Cisplatin + Pemetrexed | N | N | 250030140 | CISPLATIN + PEMETREXED |
| 250010475 | 250007678 | 1.71 | 81.3 | Disease modification (D) | 2016-05-06 | 2016-06-08 | RUXOLITINIB | 02 | N | 250030162 | RUXOLITINIB |
| 250010476 | 250007679 | 1.72 | 53.2 | Disease modification (D) | 2015-06-24 | 2015-06-24 | Cisplatin + Pemetrexed | 02 | N | 250030171 | CISPLATIN + PEMETREXED |
| 250010477 | 250007680 | null | 73 | null | 2013-04-05 | 2013-07-09 | RUXOLITINIB | N | N | 250030197 | RUXOLITINIB |
| 250010478 | 250010856 | null | 71.8 | null | 2014-12-03 | 2014-12-03 | Cisplatin + Pemetrexed | N | null | 250030209 | CISPLATIN + PEMETREXED |
| 250010479 | 250007681 | null | 79 | Palliative (P) | 2017-07-02 | 2017-07-02 | Vinorelbine (oral) | N | N | 250030213 | VINORELBINE |
| 250010480 | 250007682 | null | 50 | Curative (C) | 2015-12-23 | 2015-12-23 | Vinorelbine (oral) | 99 | N | 250030218 | VINORELBINE |
| 250010481 | 250007683 | 1.7 | 92.5 | Palliative (P) | 2014-01-17 | 2014-01-19 | RUXOLITINIB | N | N | 250030231 | RUXOLITINIB |
| 250010482 | 250007684 | 0 | 57 | Palliative (P) | 2018-07-20 | 2018-08-13 | Cisplatin + Pemetrexed | N | N | 250030232 | CISPLATIN + PEMETREXED |
| 250010483 | 250007685 | 1.78 | 68 | Disease modification (D) | 2018-12-20 | 2018-12-29 | Cisplatin + Pemetrexed | 99 | null | 250030251 | CISPLATIN + PEMETREXED |
| 250010484 | 250007686 | null | null | Palliative (P) | null | 2017-09-15 | RUXOLITINIB | 99 | N | 250030252 | RUXOLITINIB |
| 250010485 | 250007687 | 1.68 | null | null | 2018-04-21 | 2018-05-09 | Cisplatin + Pemetrexed | 02 | N | 250030256 | CISPLATIN + PEMETREXED |
| 250010486 | 250007688 | 1.67 | 0 | Palliative (P) | 2014-02-14 | 2014-03-06 | Vinorelbine (oral) | 2 | N | 250030262 | VINORELBINE |
| 250010487 | 250007689 | null | null | Adjuvant (A) | 2015-02-12 | 2015-02-12 | Cisplatin + Pemetrexed | null | N | 250030263 | CISPLATIN + PEMETREXED |
| 250010488 | 250007690 | 1.75 | 0 | Palliative (P) | 2017-02-10 | 2017-02-10 | Vinorelbine (oral) | 02 | N | 250030263 | VINORELBINE |
| 250010491 | 250007696 | 1.78 | null | Palliative (P) | 2018-09-13 | 2018-09-17 | Vinorelbine (weekly iv) | 01 | null | 250030285 | VINORELBINE |
| 250010492 | 250007697 | 1.58 | 87.9 | Not known (9) | 2016-07-21 | 2016-07-23 | VINORELBINE | 02 | N | 250030298 | VINORELBINE |